Institute of Information Science, Academia Sinica



Press Ctrl+P to print from browser

TIGP (BIO)—AI Drug Discovery -- A Case for Schizophrenia


TIGP (BIO)—AI Drug Discovery -- A Case for Schizophrenia

  • LecturerProf. Yu-Feng Jane Tseng (Department of Computer Science and Information Engineering, National Taiwan University)
    Host: TIGP (BIO)
  • Time2022-05-05 (Thu.) 14:00 – 16:00
  • LocationVirtual only

Prof. Yu-Feng Jane Tseng is the Associate Chairman of the Computer Science and Information Engineering department at National Taiwan University. In this lecture, Prof. Tseng will be giving a talk on A.I. in drug discovery, a case for schizophrenia. Artificial intelligence has been a buzzword recently. How it was applied to real drug discovery remains unknown to most people, even researchers. This talk will use our drug development and discovery case for schizophrenia treatment as an example to bring a real-world application to the audience.


Prof. Tseng is a professor at the Department of Computer Science and Information Engineering and Graduate Institute of Biomedical Electronics and Bioinformatics and School of Pharmacy at National Taiwan University (NTU). She is currently the director of SPARK Taiwan-- an organization to help bridge the gap between academic discoveries and products that benefit patients. She is also the Chairman of the Asia SPARK Regional Committee and amember of theGlobal SPARK Executive Committee. Prof. Tseng is currently the vice-chair of the Department of Computer Science and Engineering and the Neurobiology and Cognitive Science Center at National Taiwan University (NTU). She was the director of the Drug Research Center at NTU from 2015 to 2021. Professor Yufeng Jane Tseng received her B.S. degree in Pharmacy from NTU in 1997. Prof. Tseng then received her Ph.D. degree in Medicinal Chemistry and Pharmacognosy from the University of Illinois at Chicago in 2002, and was the recipient of the Charles Bell Award for Computational Chemistry in 2001. Prof. Tseng had worked as a Principal Molecular Modeling Software Developer and a drug discovery and development consultant at The Chem21 Group, Inc., in Lake Forest, USA, for ten years. From 2004 to 2006, Prof. Tseng also worked as a postdoctoral research fellow at the National Center for Biotechnology Information, National Institutes of Health in Bethesda, MD, USA. Prof. Tseng’s expertise is in AI in drug discovery, Computational Chemistry, and Bioinformatics. She is the recipient of many prestigious awards such as American Chemical Society Innovation Award (2012) and American Chemical Society Chemiluminary Award (2013), IBM Faculty Award  (2015),  BIO Asia 2020 ‘Innovation of the year Award’(2020), Taiwan National Bio-Innovation Award (2020), NTU EE Alumni Technology Innovation Award (2020), Taiwan Futuristic Breakthrough Technology Award (2019), Taiwan National Bio-Innovation Award (2019), Novartis Venture Fund Mentorship Grantee (2016 and 2017), NTU EECS Academic Merit Award (2017), Taiwan National Bio-Innovation Award (2016), Drug Repurposing Innovation Award (2015), and NTU EECS Outstanding Research Contribution Award (2013,and 2021).